Article Detail - JE Part B
Billing and Coding: Guardant360 - R2
This Local Coverage Article (LCA) is revised under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Effective Date: May 15, 2020
Summary: The article text is revised to remove “unless” from the following sentence, “Patient has not previously been tested with the Guardant360® test for the same primary cancer. For a patient who has been tested previously using Guardant360® for a cancer, that patient may only be tested again unless when the patient has a new primary cancer diagnosis. In a patient with previously tested primary cancer, who has evidence of new malignant growth, that growth may be considered to be a different primary cancer if it does not originate from the same cell line or it is physiologically different enough that it responds differently to treatment than the previously tested cancer, and…”
Visit the Noridian Medicare Coverage Articles webpages to view the locally hosted document or access it via the CMS MCD.
Last Updated Tue, 16 Jun 2020 19:06:22 +0000